Selected publications
-
Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.
Breast Cancer Research and Treatment.
2017
Academic Article
GET IT
Times cited: 3 - Factors Associated with Deciding between Risk-Reducing Salpingo-oophorectomy and Ovarian Cancer Screening among High-Risk Women Enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group Study. Obstetrical and Gynecological Survey. 2017 Comment GET IT
- Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology. 2017 Academic Article GET IT
-
Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women.
Breast Cancer Research.
2016
Academic Article
GET IT
Times cited: 4 -
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.
Nature Communications.
2016
Academic Article
GET IT
Times cited: 14 -
Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.
Breast Cancer Research.
2016
Academic Article
GET IT
Times cited: 6 -
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Gynecologic Oncology.
2016
Review
GET IT
Times cited: 2 -
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.
Nature Communications.
2016
Academic Article
GET IT
Times cited: 21 -
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.
Nature Genetics.
2016
Review
GET IT
Times cited: 29 -
Male breast cancer in BRCA1 and BRCA2 mutation carriers: Pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.
Breast Cancer Research.
2016
Academic Article
GET IT
Times cited: 22 -
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.
Journal of the National Cancer Institute.
2016
Academic Article
GET IT
Times cited: 27 -
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers.
Breast Cancer Research.
2015
Academic Article
GET IT
Times cited: 9 -
Assessing associations between the AURKAHMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers.
PLoS ONE.
2015
Academic Article
GET IT
Times cited: 4 -
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.
JAMA - Journal of the American Medical Association.
2015
Academic Article
GET IT
Times cited: 104 -
Candidate genetic modifiers for breast and ovarian cancer risk inBRCA1andBRCA2 mutation carriers.
Cancer Epidemiology Biomarkers and Prevention.
2015
Academic Article
GET IT
Times cited: 9 -
Characterization of large structural genetic mosaicism in human autosomes.
American Journal of Human Genetics.
2015
Review
GET IT
Times cited: 24 -
Identification of six new susceptibility loci for invasive epithelial ovarian cancer.
Nature Genetics.
2015
Review
GET IT
Times cited: 97 -
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers.
Breast Cancer Research.
2014
Academic Article
GET IT
Times cited: 14 -
Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33.
Human Molecular Genetics.
2014
Academic Article
GET IT
Times cited: 43 -
DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
PLoS Genetics.
2014
Academic Article
GET IT
Times cited: 18 -
Quantifying cancer absolute risk and cancer mortality in the presence of competing events after a myotonic dystrophy diagnosis.
PLoS ONE.
2013
Academic Article
GET IT
Times cited: 12 -
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk.
PLoS Genetics.
2013
Academic Article
GET IT
Times cited: 131 -
Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk.
PLoS Genetics.
2013
Academic Article
GET IT
Times cited: 64 -
A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers.
Cancer Epidemiology Biomarkers and Prevention.
2012
Academic Article
GET IT
Times cited: 12 -
Detectable clonal mosaicism and its relationship to aging and cancer.
Nature Genetics.
2012
Academic Article
GET IT
Times cited: 223 -
Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: Results from the consortium of investigators of modifiers of BRCA1/2 (CIMBA).
Cancer Epidemiology Biomarkers and Prevention.
2012
Academic Article
GET IT
Times cited: 178 -
Cancer risk among patients with myotonic muscular dystrophy.
JAMA - Journal of the American Medical Association.
2011
Academic Article
GET IT
Times cited: 46 -
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.
Breast Cancer Research.
2011
Academic Article
GET IT
Times cited: 42 -
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers.
Human Genetics.
2011
Academic Article
GET IT
Times cited: 8 -
Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.
Journal of the National Cancer Institute.
2011
Academic Article
GET IT
Times cited: 30 -
The scientific foundation for personal genomics: Recommendations from a national institutes of health-centers for disease control and prevention multidisciplinary workshop.
Genetics in Medicine.
2009
Conference Paper
GET IT
Times cited: 154